These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 43552)

  • 1. Single- and multiple-dose kinetics of estazolam, a triazolo benzodiazepine.
    Allen MD; Greenblatt DJ; Arnold JD
    Psychopharmacology (Berl); 1979; 66(3):267-74. PubMed ID: 43552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and pharmacological studies on estazolam in mice and man.
    Mancinelli A; Guiso G; Garattini S; Urso R; Caccia S
    Xenobiotica; 1985 Mar; 15(3):257-65. PubMed ID: 2862746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.
    Miller LG; Greenblatt DJ; Barnhill JG; Deutsch SI; Shader RI; Paul SM
    J Neurochem; 1987 Nov; 49(5):1595-601. PubMed ID: 2889803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacokinetics of single doses of estazolam.
    Gustavson LE; Carrigan PJ
    Am J Med; 1990 Mar; 88(3A):2S-5S. PubMed ID: 1968715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is temazepam an accumulating hypnotic?
    Ochs HR; Greenblatt DJ; Heuer H
    J Clin Pharmacol; 1984 Jan; 24(1):58-64. PubMed ID: 6142905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.
    Greenblatt DJ; Allen MD; MacLaughlin DS; Huffman DH; Harmatz JS; Shader RI
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):159-79. PubMed ID: 20218012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of estazolam, flurazepam, and placebo in outpatients with insomnia.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1986 Jul; 47(7):362-5. PubMed ID: 2873132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of estazolam. The United States clinical experience.
    Pierce MW; Shu VS; Groves LJ
    Am J Med; 1990 Mar; 88(3A):12S-17S. PubMed ID: 1968713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepines: a summary of pharmacokinetic properties.
    Greenblatt DJ; Shader RI; Divoll M; Harmatz JS
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):11S-16S. PubMed ID: 6133528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of benzodiazepine disposition by disulfiram and ethanol.
    Sellers EM; Giles HG; Greenblatt DJ; Naranjo CA
    Arzneimittelforschung; 1980; 30(5a):882-6. PubMed ID: 6106489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased number of brain benzodiazepine receptors after in-vivo administration of estazolam to rats.
    Mennini T; Gobbi M; Garattini S
    J Pharm Pharmacol; 1984 Sep; 36(9):621-2. PubMed ID: 6149289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the CYP2C19 genotype and cigarette smoking on the single oral dose pharmacokinetics and pharmacodynamics of estazolam.
    Aoshima T; Fukasawa T; Otsuji Y; Okuyama N; Gerstenberg G; Miura M; Ohkubo T; Sugawara K; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):535-8. PubMed ID: 12691790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-related effects of estazolam on sleep of patients with insomnia.
    Roehrs T; Zorick F; Lord N; Koshorek GL; Roth T
    J Clin Psychopharmacol; 1983 Jun; 3(3):152-6. PubMed ID: 6135720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam kinetics in the elderly. Relation to antipyrine disposition.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Arch Gen Psychiatry; 1983 Mar; 40(3):287-90. PubMed ID: 6131657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam kinetics in the elderly.
    Greenblatt DJ; Allen MD; Locniskar A; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1979 Jul; 26(1):103-13. PubMed ID: 36252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilatory response to single, high dose estazolam in healthy humans.
    Skatrud JB; Badr S; Begle RL; Juan D
    J Clin Pharmacol; 1990 Jun; 30(6):543-8. PubMed ID: 1972381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of two estazolam tablet formulations in Indonesian healthy volunteers.
    Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
    Arzneimittelforschung; 2008; 58(10):501-4. PubMed ID: 19025059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.